Evidence map›Paper›PMID 33842216›Full record

ReviewAnnals of cardiothoracic surgery2021

The left ventricular assist device as a patient monitoring system.

Francesco Moscato, Christoph Gross, Martin Maw, Thomas Schlöglhofer, Marcus Granegger, Daniel Zimpfer, Heinrich Schima

Registry-linked trialAbstract readReview
In one paragraph

Review in Annals of cardiothoracic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06039176 (Human/Machine Interface), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06039176 recruitingnot on this mapstarted 2023, after this paper: background citation

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

TypeobservationalSponsorInternational Consortium of Circulatory Assist CliniciansRan2023 to 2026Enrolled150ConditionsLVAD, Frailty, GI Bleed, Right Heart FailureArmsHeartMate 3 (R) left ventricular assist device
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. A scenario of left ventricular assist device suction mimicking external compression.Indian journal of thoracic and cardiovascular surgery · 2025
    Article
  6. AnFrontiers in physiology · 2023
    Article
  7. Initial clinical validation of a hybridFrontiers in physiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesco MoscatoCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Christoph GrossCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Martin MawCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Thomas SchlöglhoferCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Marcus GraneggerDivision of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Daniel ZimpferDivision of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
Heinrich SchimaCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological progress of left ventricular assist devices (LVADs) towards rotary blood pumps and the optimization of medical management contributed to the significant improvements in patient survival as well as LVAD support duration. Even though LVAD therapy is now well-established for end-stage heart failure patients, the long-term occurrence of adverse events (AE) such as bleeding, infection or stroke, still represent a relevant burden. An early detection of AE, before onset of major symptoms, can lead to further optimization of patient treatment and thus mitigate the burden of AE. Continuous patient monitoring facilitates identification of pathophysiological states and allows anticipation of AE to improve patient management. In this paper, methods, algorithms and possibilities for continuous patient monitoring based on LVAD data are reviewed. While experience with continuous LVAD monitoring is currently limited to a few centers worldwide, the pace of developments in this field is fast and we expect these technologies to have a global impact on the well-being of LVAD patients.

Indexed as

adverse events (AE)hemodynamicsLeft ventricular assist device (LVAD)patient monitoring

Identifiers

PMID33842216
PMCPMC8033254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.